Fund Holdings — Krensavage Asset Management, LLC

Total Portfolio Value
$281.9K
Total Bought
$25.4K
Total Sold
$29.9K
Net Transaction
-$4.5K
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
JAZZ PHARMACEUTICALS PLC(JAZZ)0100,000+100,0000124.36%+12
SANOFI-ADR(SNY)0150,400+150,400072.65%+7
EXELIXIS INC(EXEL)1,899,1511,899,079-72414616.16%+4
CARDINAL HEALTH INC(CAH)291,319281,476-9,843252810.07%+3
TARO PHARMACEUTICAL INDUS640,735646,453+5,71824279.58%+3
REGENERON PHARMACEUTICALS(REGN)47,25647,2560394214.73%+3
MASIMO CORP08,000+8,000010.33%+1
MURAL ONCOLOGY PLC090,833+90,833010.19%+1
BIOGEN INC(BIIB)160,480160,4800414214.73%0
ALKERMES PLC(ALKS)906,060918,038+11,97825259.04%0
KODIAK SCIENCES INC(KOD)342,3120-342,31210—-1
ENANTA PHARMACEUTICALS INC(ENTA)735,103742,824+7,721872.48%-1
UNITED THERAPEUTICS CORP(UTHR)201,222200,872-350454415.67%-1
VANDA PHARMACEUTICALS INC(VNDA)360,4290-360,42920—-2
EAGLE PHARMACEUTICALS INC112,6660-112,66620—-2
EMBECTA CORP(EMBC)1,164,8760-1,164,876180—-18
Page 1 of 1
Krensavage Asset Management, LLC — 13F Holdings — Q4 2023 | TickerTrail